Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel,

Detalhes bibliográficos
Autor(a) principal: Cury-Martins,Jade
Data de Publicação: 2020
Outros Autores: Eris,Adriana Pessoa Mendes, Abdalla,Cristina Martinez Zugaib, Silva,Giselle de Barros, Moura,Veronica Paula Torel de, Sanches,Jose Antonio
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Anais brasileiros de dermatologia (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962020000200221
Resumo: Abstract With the development of new cancer therapies, systemic toxicity profile and effects on survival achieved an important improvement. However, a constellation of toxicities has emerged, even more remarkably, cutaneous adverse events. This report, developed by a board of Brazilian experts in oncodermatology, aims to establish a guideline for the dermatological care of oncologic patients. When possible, evidence-based recommendations were made, but in many cases, when strong evidence was not available, a consensus was reached, based on some data supporting therapies combined with personal experiences.
id SBD-1_17c91635f4377e8fb407d61a523960e7
oai_identifier_str oai:scielo:S0365-05962020000200221
network_acronym_str SBD-1
network_name_str Anais brasileiros de dermatologia (Online)
repository_id_str
spelling Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel,Antineoplastic agentsAntineoplastic agents, immunologicalDermatologyDrug-related side effects and adverse reactionsMedical oncologyMolecular targeted therapyAbstract With the development of new cancer therapies, systemic toxicity profile and effects on survival achieved an important improvement. However, a constellation of toxicities has emerged, even more remarkably, cutaneous adverse events. This report, developed by a board of Brazilian experts in oncodermatology, aims to establish a guideline for the dermatological care of oncologic patients. When possible, evidence-based recommendations were made, but in many cases, when strong evidence was not available, a consensus was reached, based on some data supporting therapies combined with personal experiences.Sociedade Brasileira de Dermatologia2020-03-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962020000200221Anais Brasileiros de Dermatologia v.95 n.2 2020reponame:Anais brasileiros de dermatologia (Online)instname:Sociedade Brasileira de Dermatologia (SBD)instacron:SBD10.1016/j.abd.2020.01.001info:eu-repo/semantics/openAccessCury-Martins,JadeEris,Adriana Pessoa MendesAbdalla,Cristina Martinez ZugaibSilva,Giselle de BarrosMoura,Veronica Paula Torel deSanches,Jose Antonioeng2020-07-03T00:00:00Zoai:scielo:S0365-05962020000200221Revistahttp://www.anaisdedermatologia.org.br/https://old.scielo.br/oai/scielo-oai.phpabd@sbd.org.br||revista@sbd.org.br1806-48410365-0596opendoar:2020-07-03T00:00Anais brasileiros de dermatologia (Online) - Sociedade Brasileira de Dermatologia (SBD)false
dc.title.none.fl_str_mv Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel,
title Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel,
spellingShingle Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel,
Cury-Martins,Jade
Antineoplastic agents
Antineoplastic agents, immunological
Dermatology
Drug-related side effects and adverse reactions
Medical oncology
Molecular targeted therapy
title_short Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel,
title_full Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel,
title_fullStr Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel,
title_full_unstemmed Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel,
title_sort Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel,
author Cury-Martins,Jade
author_facet Cury-Martins,Jade
Eris,Adriana Pessoa Mendes
Abdalla,Cristina Martinez Zugaib
Silva,Giselle de Barros
Moura,Veronica Paula Torel de
Sanches,Jose Antonio
author_role author
author2 Eris,Adriana Pessoa Mendes
Abdalla,Cristina Martinez Zugaib
Silva,Giselle de Barros
Moura,Veronica Paula Torel de
Sanches,Jose Antonio
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Cury-Martins,Jade
Eris,Adriana Pessoa Mendes
Abdalla,Cristina Martinez Zugaib
Silva,Giselle de Barros
Moura,Veronica Paula Torel de
Sanches,Jose Antonio
dc.subject.por.fl_str_mv Antineoplastic agents
Antineoplastic agents, immunological
Dermatology
Drug-related side effects and adverse reactions
Medical oncology
Molecular targeted therapy
topic Antineoplastic agents
Antineoplastic agents, immunological
Dermatology
Drug-related side effects and adverse reactions
Medical oncology
Molecular targeted therapy
description Abstract With the development of new cancer therapies, systemic toxicity profile and effects on survival achieved an important improvement. However, a constellation of toxicities has emerged, even more remarkably, cutaneous adverse events. This report, developed by a board of Brazilian experts in oncodermatology, aims to establish a guideline for the dermatological care of oncologic patients. When possible, evidence-based recommendations were made, but in many cases, when strong evidence was not available, a consensus was reached, based on some data supporting therapies combined with personal experiences.
publishDate 2020
dc.date.none.fl_str_mv 2020-03-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962020000200221
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962020000200221
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1016/j.abd.2020.01.001
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Dermatologia
publisher.none.fl_str_mv Sociedade Brasileira de Dermatologia
dc.source.none.fl_str_mv Anais Brasileiros de Dermatologia v.95 n.2 2020
reponame:Anais brasileiros de dermatologia (Online)
instname:Sociedade Brasileira de Dermatologia (SBD)
instacron:SBD
instname_str Sociedade Brasileira de Dermatologia (SBD)
instacron_str SBD
institution SBD
reponame_str Anais brasileiros de dermatologia (Online)
collection Anais brasileiros de dermatologia (Online)
repository.name.fl_str_mv Anais brasileiros de dermatologia (Online) - Sociedade Brasileira de Dermatologia (SBD)
repository.mail.fl_str_mv abd@sbd.org.br||revista@sbd.org.br
_version_ 1752126423844257792

Registros relacionados